
Vikas Pejaver, PhD
About Me
Dr. Vikas Pejaver is an Assistant Professor at the Institute for Genomic Health and the Department of Genetics and Genomic Sciences in the Icahn School of Medicine at Mount Sinai. His research focuses on the development and application of machine learning methods to relate genetic variation to molecular function and disease phenotypes, with a particular emphasis on rare variants and diseases. His work utilizes a broad array of machine learning techniques on genomic, protein and electronic health record data sets. Dr. Pejaver has a Bachelor’s degree in Biotechnology from the People’s Education Society (PES) Institute of Technology (now PES University) in Bengaluru, India. After that, he received his Master’s degree in Bioinformatics and doctoral degree in Informatics from the School of Informatics and Computing (now School of Informatics, Computing and Engineering) at Indiana University, Bloomington. Dr. Pejaver then completed his postdoctoral training at the Department of Biomedical Informatics and Medical Education (BIME) and the eScience Institute at the University of Washington (UW), where he received the Moore/Sloan and Washington Research Foundation Innovation in Data Science Postdoctoral Fellowship. He also received a K99/R00 Pathway to Independence Award from the National Library of Medicine at the National Institutes of Health. At UW, he was also awarded the Fred Wolf Mentorship Award for his active roles in training and mentoring students in BIME.
Language
English
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences, ASSISTANT PROFESSOR | Artificial Intelligence and Human Health
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
Publications
Selected Publications
- The IGVF catalog—from genetic variation to function. Daofeng Li, Shane Liu, Pedro R. Assis, Mingjie Li, Shengcheng Dong, Ian Whaling, Otto Jolanki, Meenakshi Kagda, Wenjin Zhang, Juan F. Macias-Velasco, Tianjie Liu, Sarah Cody, Lucinda Antonacci-Fulton, Yuanhao Huang, Jie Liu, Michael T. Montgomery, Daniel Zeiberg, Shantanu Jain, Vikas Pejaver, Timothy Bergquist, Yile Chen, Predrag Radivojac, Charles A. Gersbach, Rintsen N. Sherpa, Christopher P. Castro, Alan P. Boyle, Lea M. Starita, Douglas M. Fowler, Nadav Ahituv, Kushal K. Dey, William H. Majoros, Timothy E. Reddy, Mark Craven, Riya Sinha, Yuriy Sverchkov, Xiangmeng Cai, Mpathi Z. Nzima, Michael A. Calderwood, Joel Rozowsky, Mark Gerstein, Jian Ma, Feng Yue, Michael M. Cherry, Michael I. Love, Jesse M. Engreitz, Benjamin C. Hitz, Ting Wang. Nucleic Acids Research
- Drivers of Diagnostic Delay in Mitochondrial Disease: Missed Recognition of Canonical Features. Rory J. Tinker, Neil Jacob, Mohammad Ghouse Syed, Janhawi Kelkar, Colleen Donnelly, Ibrahim Elsharkawi, Jaya Ganesh, Bruce D. Gelb, Vikas Pejaver, Tamas Kozicz, Eva Morava. JIMD Reports
- Extracting and calibrating evidence of variant pathogenicity from population biobank data. Vineel Bhat, Tian Yu, Lara Brown, Vikas Pejaver, Matthew Lebo, Steven Harrison, Christopher A. Cassa. American Journal of Human Genetics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Pejaver during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services
Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership- Northeastern University
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.